Benitec Biopharma Inc.

Direct answer

Benitec Biopharma Inc. is publicly traded on NASDAQ under the ticker BNTC.

Benitec Biopharma Inc. is an emerging biotechnology firm dedicated to advancing groundbreaking genetic medicines. The company specializes in DNA-directed RNA interference (RNAi) based treatments, which it develops to address severe and enduring human conditions. Its pipeline features BB-301, an adeno-associated virus (AAV) gene therapy aimed at treating oculopharyngeal muscular dystrophy, and BB-103, designed to...

Can you invest in Benitec Biopharma Inc.?

Yes. Benitec Biopharma Inc. is publicly traded on NASDAQ under the ticker BNTC.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Benitec Biopharma Inc.

Detailed equity research is provided by MarketSnap.